Voomi Supply | $10,000,000 | (Mar 10, 2026)
Axiomatic_AI | $18,000,000 | (Mar 10, 2026)
Advocacy | $3,500,000 | (Mar 10, 2026)
Certified by Founder
Lodge
NeuroSense Therapeutics
start up
United States
- Cambridge, Massachusetts
- 09/12/2021
- Unknown
- $12,000,000
Advancing research, development and therapy for ALS and additional CNS indications.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Currently in preparations towards a Phase IIb in ALS patients in USA and Israel.
- Industry Biotechnology Research
- Website http://www.neurosense-tx.com/
- LinkedIn https://www.linkedin.com/company/neurosense-therapeutics/about/
Related People
Alon Ben-NoonCo Founder
Israel -
Herzliyya, Tel Aviv
Life Sciences Executive ; Leading NeuroSense Therapeutics, a Biotech startup which accelerates research, development and therapy for ALS (Amyotrophic Lateral Sclerosis) and additional Neurodegenerative diseases.
LinkedIn
https://www.linkedin.com/in/alonbn/
Crafting | $5,500,000 | (Mar 10, 2026)
Cylake | $45,000,000 | (Mar 10, 2026)
Augur | $15,000,000 | (Mar 10, 2026)
ANEUVO | $22,000,000 | (Mar 10, 2026)
DiligenceSquared (YC F25) | $5,000,000 | (Mar 10, 2026)
Mirai Robotics | $4,200,000 | (Mar 10, 2026)
Dify | $30,000,000 | (Mar 10, 2026)
Mega | $11,500,000 | (Mar 10, 2026)
Denki (YC F25) | $4,100,000 | (Mar 10, 2026)
KAST | $80,000,000 | (Mar 10, 2026)